🇺🇸 FDA

Company profile · Sponsor

Repatha

J753B11 · PMDA pharma JP
Pipeline
3
Drugs
0
Patents
0

Quick answer

Repatha (J753B11) is a pharma company. headquartered in JP. listed on PMDA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker J753B11
Exchange PMDA
Company type pharma
Headquarters JP

Pipeline (3)

Search pipeline →

  1. Live attenuated SA 14-14-2 vaccine

    Repatha

    Encephalitis, Japanese B

    phase 3 mab completed

    1 trial

  2. IVACFLU

    Repatha

    Influenza

    phase 1 mab completed

    1 trial

  3. primaquine

    Repatha

    Malaria, Vivax

    approved small molecule terminated

    1 trial

Frequently asked questions

What is Repatha?

Repatha (J753B11) is a pharma company. headquartered in JP. listed on PMDA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Repatha sponsor?

We track 3 ClinicalTrials.gov-linked programs for Repatha, including Live attenuated SA 14-14-2 vaccine and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Repatha company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.